ReShape Lifesciences Inc. (NASDAQ:RSLS) Sees Large Increase in Short Interest

ReShape Lifesciences Inc. (NASDAQ:RSLS) was the target of a significant growth in short interest during the month of February. As of February 15th, there was short interest totalling 82,800 shares, a growth of 266.4% from the January 31st total of 22,600 shares. Based on an average trading volume of 930,400 shares, the short-interest ratio is currently 0.1 days. Approximately 62.6% of the company’s shares are sold short.

ReShape Lifesciences Price Performance

Shares of RSLS traded down $0.07 during mid-day trading on Friday, hitting $1.03. The company had a trading volume of 701,243 shares, compared to its average volume of 1,568,588. The business’s 50-day simple moving average is $3.54 and its 200-day simple moving average is $5.55. ReShape Lifesciences has a 1-year low of $0.98 and a 1-year high of $29.00.

About ReShape Lifesciences

ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.